Maxim Group Downgrades Amryt Pharma to Hold

Maxim Group analyst Jason McCarthy downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Hold.

Maxim Group analyst Jason McCarthy downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Hold.

Total
0
Shares
Related Posts
Read More

What’s Going On With Ford Shares

Ford Motor Co (NYSE: F) shares are trading lower by 3.97% to $13.20 Friday morning following second-quarter earnings. The stock also received a number of analyst rating updates following the earnings print.

F